IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...

USA-based biotech IMMvention Therapeutix yesterday revealed it has entered into a strategic collaboration and license ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co ...

IMMvention and Novo Nordisk form a partnership to co-develop oral therapies for sickle cell disease, focusing on BACH1 ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...

DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...

Eli Lilly and Novo Nordisk's rivalry mirrors the larger dynamics of the weight-loss medicine business, where clinical success and invention define market supremacy. Eli Lilly's new FDA clearance ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Beyond this latest recognition, Musk's impact on the world extends far beyond a single year, evidenced by a series of groundbreaking inventions ... Mads Krogsgaard of Novo Nordisk also garnered ...

and Novo Nordisk, and the emergence of various techbio companies like Archon Biosciences, Genesis Therapeutics, and Xaira.

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...